CASE STUDY. UBX1325 MoA in Diabetic Macular Edema for Unity Biotechnology (NAS: UBX)
Learn more https://visual-science.com/unity
Видео CASE STUDY. UBX1325 MoA in Diabetic Macular Edema for Unity Biotechnology (NAS: UBX) канала Visual Science
Видео CASE STUDY. UBX1325 MoA in Diabetic Macular Edema for Unity Biotechnology (NAS: UBX) канала Visual Science
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Scientific animation for drug-hunting platform. Scorpion Therapeutics
CASE STUDY. MoA animations about virus-based immunotherapy platforms for Candel Therapeutics (NA...
CASE STUDY. UNI-494 drug Mechanism of Action for Unicycive Therapeutics (NAS: UNCY)
CASE STUDY. UBX1325 MoA in Age-related Macular Degeneration for Unity Biotechnology (NAS: UBX)
3D animation-presentation type
LineaRx enzymatic platform for large-scale DNA manufacturing
MoA animation for Atsena Therapeutics' investor deck and website
Atsena Therapeutics: Dual Vector animation. MoA animation
Enterin ENT-01 MoA animation
Visual Science MoA/MoD animations. Demoreel 2023
High-end 3D animation on LINE-1 reverse transcriptase
Visual Science MoA animation Reel 2023
Unity Biotechnology UBX1325 MoA on AMD @Visual Science
CASE STUDY. Mechanism of Action animation about Redpin Tx's (acquired by Kriya Therapeutics) che...
Quantitative Amplicon Sequencing (QASeq) NUPROBE 3D animation by Visual-Science
CASE STUDY. Mechanism of Action animation for Enterin
Neoleukin NL-201 MoA animation. De novo protein development platform
pH-Low Insertion Peptide Platform Technology for targeted delivery
Visual Cortex Activation. 3D animation for holographic projection
How do CRISPR gene-editing systems work?
Botulotoxin A animation short